Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 12, 2016 - Issue 11
Submit an article Journal homepage
1,166
Views
6
CrossRef citations to date
0
Altmetric
Research Papers

Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults

Huai WangBeijing Center for Disease Control and Prevention, Beijing, China
,
Binyu CaiXuanhua District Center for Disease Control and Prevention, Hebei, China
,
Delong RaoHuaibei District Center for Disease Control and Prevention, Anhui, China
,
Min LiuHuaibei District Center for Disease Control and Prevention, Anhui, China
,
Yabin LiXuanhua District Center for Disease Control and Prevention, Hebei, China
,
Xiaofeng LiangChinese Center for Disease Control and Prevention, Beijing, China
,
Fuqiang CuiChinese Center for Disease Control and Prevention, Beijing, China
,
Guomin ZhangChinese Center for Disease Control and Prevention, Beijing, China
,
Fuzhen WangChinese Center for Disease Control and Prevention, Beijing, China
,
Xinghuo PangBeijing Center for Disease Control and Prevention, Beijing, China
,
Li NieBeijing Center for Disease Control and Prevention, Beijing, China
,
Qian QiuBeijing Center for Disease Control and Prevention, Beijing, China
,
Jiang WuBeijing Center for Disease Control and Prevention, Beijing, China
,
Liqiu LiBeijing Center for Disease Control and Prevention, Beijing, China
,
Fang HuangBeijing Center for Disease Control and Prevention, Beijing, China
&
Wei ZhangBeijing Center for Disease Control and Prevention, Beijing, ChinaCorrespondence[email protected]
 show all
Pages 2921-2926 | Received 25 Feb 2016, Accepted 20 Jun 2016, Published online: 20 Sep 2016

References

  • World Health Organization, Hepatitis B. http://www.who.int/mediacentre/factsheets/fs204/en/
  • Wang F, Shen L, Cui F, Zhang S, Zheng H, Zhang Y, Liang X, Wang F, Bi S. The long-term efficacy, 13–23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China. Vaccine 2015; 33(23):2704-9; PMID:25843269; http://dx.doi.org/10.1016/j.vaccine.2015.03.064
  • Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27(47):6550-7; PMID:19729084; http://dx.doi.org/10.1016/j.vaccine.2009.08.048
  • Pan HX, Zeng Y, Song XF, Zhang YJ, Xu K, Liang ZL, Zhu FC. Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults. Vaccine 2014; 32(29):3706-12; PMID:24681228
  • Bock HL, Löscher T, Scheiermann N, Baumgarten R, Wiese M, Dutz W, Sänger R, Clemens R. Accelerated schedule for hepatitis B immunization. J of Travel Med 1995; 2(4):213-7.
  • Halperin SA, McNeil S, Langley JM, Smith B, MacKinnon-Cameron D, McCall-Sani R, Heyward WL, Martin JT. Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults. Vaccine 2012; 30(36):5445-8; PMID:22704926; http://dx.doi.org/10.1016/j.vaccine.2012.05.074
  • Velu V, Nandakumar S, Shanmugam S, Shankar EM, Thangavel S, Kulkarni PS, Thyagarajan SP. Comparative Efiicacy of two dosage of recombinant hepatitis B vaccine in healthy adulescents in India. Pediat Infect Dis J 2007; 26(11):1038-41; PMID:17984812; http://dx.doi.org/10.1097/INF.0b013e3181342887
  • De Schryver A, Verstrepen K, Vandersmissen L, Vandermeeren N, Vernaillen I, Vranckx R, Van Damme P, van Sprundel M. Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers. J Viral Hepatitits 2011; 18(4):e5-e10; http://dx.doi.org/10.1111/j.1365-2893.2010.01365.x
  • Rendi-Wagner P, Kundi M, Stemberger H, Wiedermann G, Holzmann H, Hofer M, Wiesinger K, Kollaritsch H. Antibody response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine 2001; 19(15–16):2055-60; PMID:11228377; http://dx.doi.org/10.1016/S0264-410X(00)00410-2
  • Zhang W, Han L, Lin C, Wang H, Pang X, Li L, Gao P, Lin H, Gong X, Tang Y, et al. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine. Vaccine 2011; 29(2011):6276-82; PMID:21722684
  • Herona LG, Chanta KG, Jalaludinb BB. A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart. Vaccine 2002; 20(29–30):3472-6; PMID:12297392; http://dx.doi.org/10.1016/S0264-410X(02)00346-8
  • Burgess MA, McIntyre PB, Hellard M, Ruff TA, Lefevre I, Bock HL. Antibody persistence six years after two doses of combined hepatitis A and B vaccine. Vaccine 2010; 28(10):2222-6; PMID:20056187; http://dx.doi.org/10.1016/j.vaccine.2009.12.053
  • Cassidy WM, Watson B, Ioli VA, Williams K, Bird S, West DJ. A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Pediatrics 2001; 107(4):626-31; PMID:11335734; http://dx.doi.org/10.1542/peds.107.4.626
  • Kane MA. Global status of hepatitis B immunisation. Lancet 1996; 348:696; PMID:8806283; http://dx.doi.org/10.1016/S0140-6736(05)65598-5
  • Advisory Committee on Immunization Practices. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991; 40(RR-13):1-19
  • Centers for Disease Control and Prevention. Hepatitis B vaccination among high-risk adolescents and adults – San Diego, California, 1998–2001. MMWR Morb Mortal Wkly Rep 2002; 51:618-21; PMID:12236303
  • Stoffel M, Lievens M, Dieussaet I, Martin I, André F. Immunogenicity of Twinrix in older adults: a critical analysis. Expert Rev Vaccines 2003; 2(1):9-14; PMID:12901592; http://dx.doi.org/10.1586/14760584.2.1.9
  • Van der Wielen M, Van Damme P, Chlibek R, Smetana J, von Sonnenburg F. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. Vaccine 2006; 24(26):5509-15; PMID:16725234; http://dx.doi.org/10.1016/j.vaccine.2006.04.016

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.